Nicola Clementi
Citata da
Citata da
Type III interferons disrupt the lung epithelial barrier upon viral recognition
A Broggi, S Ghosh, B Sposito, R Spreafico, F Balzarini, A Lo Cascio, ...
Science 369 (6504), 706-712, 2020
The interferon landscape along the respiratory tract impacts the severity of COVID-19
B Sposito, A Broggi, L Pandolfi, S Crotta, N Clementi, R Ferrarese, S Sisti, ...
Cell 184 (19), 4953-4968. e16, 2021
Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry systems for identification …
N Mancini, E De Carolis, L Infurnari, A Vella, N Clementi, L Vaccaro, ...
Journal of clinical microbiology 51 (7), 2453-2457, 2013
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
N Clementi, C Scagnolari, A D’Amore, F Palombi, E Criscuolo, F Frasca, ...
Pharmacological research 163, 105255, 2021
Alternative methods of vaccine delivery: an overview of edible and intradermal vaccines
E Criscuolo, V Caputo, RA Diotti, GA Sautto, GA Kirchenbaum, ...
Journal of immunology research 2019, 2019
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
M Stravalaci, I Pagani, EM Paraboschi, M Pedotti, A Doni, F Scavello, ...
Nature Immunology, 2022
Viral respiratory pathogens and lung injury
N Clementi, S Ghosh, M De Santis, M Castelli, E Criscuolo, I Zanoni, ...
Clinical microbiology reviews 34 (3), 10.1128/cmr. 00103-20, 2021
Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures
N Mancini, L Infurnari, N Ghidoli, G Valzano, N Clementi, R Burioni, ...
Journal of clinical microbiology 52 (4), 1242-1245, 2014
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials
E Criscuolo, RA Diotti, R Ferrarese, C Alippi, G Viscardi, C Signorelli, ...
Emerging Microbes & Infections 10 (1), 206-209, 2021
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
GA Sautto, K Wisskirchen, N Clementi, M Castelli, RA Diotti, J Graf, ...
Gut 65 (3), 512-523, 2016
A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes
N Clementi, D De Marco, N Mancini, L Solforosi, GJ Moreno, ...
PloS one 6 (12), e28001, 2011
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes
N Mancini, RA Diotti, M Perotti, G Sautto, N Clementi, G Nitti, AH Patel, ...
PloS one 4 (12), e8254, 2009
Interferon-β-1a inhibition of severe acute respiratory syndrome–coronavirus 2 in vitro when administered after virus infection
N Clementi, R Ferrarese, E Criscuolo, RA Diotti, M Castelli, C Scagnolari, ...
The Journal of infectious diseases 222 (5), 722-725, 2020
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens
N Clementi, N Mancini, L Solforosi, M Castelli, M Clementi, R Burioni
International Journal of Molecular Sciences 13 (7), 8273-8292, 2012
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic
A Lai, A Bergna, S Caucci, N Clementi, I Vicenti, F Dragoni, AM Cattelan, ...
Viruses 12 (8), 798, 2020
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
N Mancini, L Solforosi, N Clementi, D De Marco, M Clementi, R Burioni
Antiviral research 92 (1), 15-26, 2011
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
M Severa, RA Diotti, MP Etna, F Rizzo, S Fiore, D Ricci, M Iannetta, ...
bioRxiv, 2021
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)
R Burioni, F Canducci, N Mancini, N Clementi, M Sassi, D De Marco, ...
Virology 399 (1), 144-152, 2010
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses
D De Marco, N Clementi, N Mancini, L Solforosi, GJ Moreno, X Sun, ...
PLoS One 7 (4), e34415, 2012
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
A Conforti, E Marra, F Palombo, G Roscilli, M Ravà, V Fumagalli, A Muzi, ...
Molecular Therapy 30 (1), 311-326, 2022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20